Relmada Therapeutics Inc (NAS:RLMD)
$ 5.38 +0.39 (+7.81%) Market Cap: 565.36 Mil Enterprise Value: 331.39 Mil PE Ratio: 0 PB Ratio: 2.58 GF Score: 29/100

Relmada Therapeutics Inc Annual Shareholders Meeting Transcript

May 27, 2026 / 01:30PM GMT
Release Date Price: $7.26 (+1.26%)
Operator

Thank you for standing by. I would like to welcome you to the Relmada Therapeutics, Inc. Annual Meeting. I would now like to turn the conference over to Sergio Traverza, CEO. Please go ahead.

Sergio Traversa
Relmada Therapeutics Inc - Chief Executive Officer, Director

Good morning, everyone. Welcome to our Virtual 2026 Annual Meeting of Stockholder of Relmada Therapeutics, Inc. I'm Sergio Traverza, Chief Executive Officer of Relmada, and it is my pleasure to welcome all of you. It is 9:30 AM, and in accordance with the notice of the meeting, I will call to order the Annual Meeting of Stockholders of Relmada Therapeutics.

After the formal meeting has ended, we will provide time for general questions. Only validated stockholders may ask questions in the designated field on the web portal. Out of consideration for others, please limit yourself to one question.

Based on information received from Chandi Jackson, our Inspector of Election, 63.5% in voting power of the shares of the corporation entitled to vote at the meeting are present in person

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot